Is VRTX stock safe? | Glauxie AI

Q: Is VRTX stock safe?

Vertex Pharmaceuticals Incorporated (VRTX) operates in the Biotechnology industry (Healthcare sector). The company is led by CEO Reshma Kewalramani. Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and... Employees: 6,400.

Q: What are the risks of investing in VRTX?

Identify key risks of investing in VRTX — debt, competition, volatility, and sector headwinds.

Q: Is VRTX a good long-term investment?

Evaluate VRTX as a long-term investment using fundamental scores, growth metrics, and risk assessment.

Q: How much debt does VRTX have?

Review VRTX total debt, debt-to-equity ratio, interest coverage, and leverage trends.

Is VRTX stock safe?

🦉

Vertex Pharmaceuticals Incorporated (VRTX)

Company Overview

Sector / IndustryHealthcare / Biotechnology

CEOReshma Kewalramani

Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis...

Key Executives

Name	Title
Amit K. Sachdev	Executive Vice President & Chief Patient and External Affairs Officer
Carmen Bozic	Executive VP of Global Medicines Development & Medical Affairs and Chief Medical Officer
Charles F. Wagner Jr.	Executive Vice President, Chief Operating Officer & Chief Financial Officer
David Altshuler	Executive Officer
Duncan J. McKechnie	Chief Commercial Officer, Head of North America Commercial & Executive VP
Edward Morrow Atkinson	EVP, Chief Technical Operations Officer & Head of Biopharmaceutical Sciences and Manufacturing Ops.

Financial Health

Risk Assessment

Weather Score0/100

RegimeN/A

VRTX Profile Financials

What are the risks of investing in VRTX? Is VRTX a good long-term investment? How much debt does VRTX have?